KRISTINA ALLRED: Open Payments
NPI 1760028393 · POWDERSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 54 payments from 10 companies in 2025. Trend: 2023 $663 · 2024 $1,410 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $509 |
| ABBVIE INC. | 15 | $260 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Novo Nordisk Inc | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Lundbeck LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
Products named: VRAYLAR, AIRSUPRA, FARXIGA, REXULTI, TRELEGY ELLIPTA, BREZTRI, CAPLYTA, ELIQUIS.
Industry payments across SC — which companies pay providers there.
